Crispr Therapeutics Ag (NQ: CRSP )

121.55 USD +11.55 (+10.50%)

Official Closing Price Updated: 4:58 PM EST, Nov 27, 2020 Add to My Watchlist

Price and Volume

Volume	1,124,300
Open	111.08
Bid (Size)	120.58 (1)
Ask (Size)	123.20 (2)
Prev. Close	110.00
Today's Range	110.36 - 124.43
52wk Range	32.30 - 124.43
Shares Outstanding	46,842,969
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 24, 2020

CRISPR Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference

November 16, 2020

Performance

YTD	+103.94%	+103.94%
1 Month	+28.34%	+28.34%
3 Month	+34.00%	+34.00%
6 Month	+88.22%	+88.22%
1 Year	+69.64%	+69.64%

More News

CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition

November 04, 2020

Are These The Best Biotech Stocks To Watch In November 2020?

November 11, 2020

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results

October 28, 2020

What Are The Best Biotech Stocks To Watch Before November? 3 For Your List

October 28, 2020

CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies

October 21, 2020

First Week of July 2021 Options Trading For CRISPR Therapeutics (CRSP)

November 23, 2020

Is Gene Editing Already Leaving CRISPR Therapeutics Behind?

November 21, 2020

Why This Gene-Editing Player Just Outpaced Bullish Biotech Stocks

November 04, 2020

12 Healthcare Stocks Moving In Wednesday's Pre-Market Session

October 21, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.